Biosig technologies, inc. (BSGM)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Dec'13
ASSETS
Current assets:
Cash

15,499

12,108

12,308

10,333

10,933

4,450

7,279

3,673

1,035

1,547

234

880

1,244

1,055

150

705

137

953

334

1,197

2,059

239

268

42

302

Inventory

800

577

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Vendor deposits

100

-

430

-

-

100

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

160

141

143

306

156

78

146

166

119

116

150

175

161

134

134

141

11

31

201

149

159

75

100

21

0

Total current assets

16,560

12,827

12,882

10,640

11,090

4,628

7,425

3,839

1,154

1,664

384

1,055

1,405

1,190

284

846

148

984

535

1,346

2,219

315

369

63

302

Property and equipment, net

184

180

102

77

53

44

31

21

19

18

18

16

22

24

22

18

15

18

14

16

12

13

16

16

24

Right-to-use assets, net

614

714

732

813

380

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets:
Patents, net

359

364

369

374

324

268

227

258

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Trademarks

1

1

1

1

1

0

0

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses, long term

18

27

32

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposits

101

101

101

155

54

54

61

59

22

17

19

27

27

27

27

27

27

27

27

27

25

25

25

25

25

Total assets

17,840

14,217

14,221

12,062

11,904

4,996

7,747

4,177

1,196

1,700

423

1,099

1,456

1,241

335

893

192

1,030

577

1,391

2,256

353

410

105

352

LIABILITIES AND EQUITY
Current liabilities:
Accounts payable and accrued expenses, including $115,117 and $39,674 to related parties as of March 31, 2020 and December 31, 2019, respectively

1,033

1,488

724

942

597

954

463

219

338

473

1,301

1,242

582

373

426

271

228

223

342

266

320

554

443

552

819

Dividends payable

127

128

123

118

253

242

256

305

482

447

396

382

383

359

341

316

367

340

337

338

456

445

393

330

414

Lease liability, short term

423

412

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock based payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

132

646

226

-

-

0

Advances, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

30

Lease liability, short term

-

-

365

352

158

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

52

Warrant liability

-

-

-

-

-

-

0

0

0

2,358

2,240

2,364

2,302

1,937

2,324

2,325

1,878

1,621

1,816

4,056

4,097

0

-

-

-

Derivative liability

-

-

-

-

-

-

0

0

0

685

285

279

297

288

291

308

283

285

220

897

1,242

0

-

-

-

Total current liabilities

1,584

2,029

1,213

1,414

1,009

1,197

720

525

821

3,965

4,224

4,269

3,565

2,959

3,383

3,221

2,758

2,470

2,717

5,692

6,763

1,225

837

883

3,017

Lease liability, long term

201

311

375

468

226

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total debt

1,785

2,340

-

-

-

1,197

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total debt

-

-

1,588

1,882

1,235

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred Stock

205

215

215

215

475

475

475

575

965

985

985

1,005

1,070

1,070

1,090

1,090

1,396

1,471

1,858

2,058

2,461

2,711

2,781

2,766

2,297

Commitments and contingencies (Note 11)

-

-

-

-

-

-

0

0

115

-

0

0

0

0

-

-

-

0

-

-

-

0

-

-

-

Equity:
Preferred stock

0

0

0

0

0

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.001 par value, authorized 200,000,000 shares, 26,010,318 and 23,323,087 issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

26

23

22

21

20

16

16

36

30

11

26

25

24

22

20

20

17

16

15

14

13

11

11

9

8

Additional paid in capital

131,339

115,910

101,483

94,494

86,465

74,039

71,571

64,925

55,381

53,233

46,888

45,740

43,898

41,019

38,295

37,478

30,845

29,314

26,204

24,220

18,852

19,186

16,883

12,524

9,036

Subscriptions

-

-

501

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock subscription

-

-

-

-

309

-

-

-

-

29

279

239

-

-

-

-

-

0

-

-

-

-

-

-

-

Accumulated deficit

-116,122

-104,786

-89,994

-84,551

-76,601

-70,731

-65,035

-61,884

-56,117

-56,524

-51,980

-50,180

-47,101

-43,829

-42,454

-40,917

-34,824

-32,241

-30,217

-30,594

-25,833

-22,780

-20,102

-16,079

-14,007

Total stockholders' equity attributable to BioSig Technologies, Inc

15,243

11,146

12,012

9,965

10,193

3,324

6,552

3,077

-590

-3,249

-4,785

-4,174

-3,179

-2,787

-4,138

-3,417

-3,962

-2,910

-3,997

-6,359

-6,967

-3,583

-3,207

-3,544

-4,962

Non-controlling interest

607

514

405

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total equity

15,850

11,661

12,417

-

-

3,324

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities and equity

17,840

14,217

14,221

12,062

11,904

4,996

7,747

4,177

1,196

1,700

423

1,099

1,456

1,241

335

893

192

1,030

577

1,391

2,256

353

410

105

352

Series D Preferred Stock [Member]
Preferred stock

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-